1h Free Analyst Time
The peripheral neuropathy treatment market and is poised to grow by $372.56 mn from 2023-2027, accelerating at a CAGR of 3.81% during the forecast period. The report on the peripheral neuropathy treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of peripheral neuropathy, recent drug approvals for peripheral neuropathy, and raising awareness of peripheral neuropathy.
The peripheral neuropathy treatment market is segmented as below:
By Type
- Diabetic peripheral neuropathy
- Chemotherapy-induced peripheral neuropathy
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the peripheral neuropathy treatment market covers the following areas:
- Peripheral neuropathy treatment market sizing
- Peripheral neuropathy treatment market forecast
- Peripheral neuropathy treatment market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market through the study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Market Segmentation by Therapy
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
4.1 Global peripheral neuropathy treatment market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on Global peripheral neuropathy treatment market 2017 - 2021 ($ million)
4.2 Type Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
4.3 Treatment Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Treatment Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Type
6.1 Market segments
Exhibit 30: Chart on Type - Market share 2022-2027 (%)
Exhibit 31: Data Table on Type - Market share 2022-2027 (%)
6.2 Comparison by Type
Exhibit 32: Chart on Comparison by Type
Exhibit 33: Data Table on Comparison by Type
6.3 Diabetic peripheral neuropathy - Market size and forecast 2022-2027
Exhibit 34: Chart on Diabetic peripheral neuropathy - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Diabetic peripheral neuropathy - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Diabetic peripheral neuropathy - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Diabetic peripheral neuropathy - Year-over-year growth 2022-2027 (%)
6.4 Chemotherapy induced peripheral neuropathy - Market size and forecast 2022-2027
Exhibit 38: Chart on Chemotherapy induced peripheral neuropathy - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Chemotherapy induced peripheral neuropathy - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Chemotherapy induced peripheral neuropathy - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Chemotherapy induced peripheral neuropathy - Year-over-year growth 2022-2027 (%)
6.5 Others - Market size and forecast 2022-2027
Exhibit 42: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Others - Year-over-year growth 2022-2027 (%)
6.6 Market opportunity by Type
Exhibit 46: Market opportunity by Type ($ million)
7 Market Segmentation by Therapy
7.1 Market segments
Exhibit 47: Chart on Therapy - Market share 2022-2027 (%)
Exhibit 48: Data Table on Therapy - Market share 2022-2027 (%)
7.2 Comparison by Therapy
Exhibit 49: Chart on Comparison by Therapy
Exhibit 50: Data Table on Comparison by Therapy
7.3 Pharmacological therapies - Market size and forecast 2022-2027
Exhibit 51: Chart on Pharmacological therapies - Market size and forecast 2022-2027 ($ million)
Exhibit 52: Data Table on Pharmacological therapies - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Chart on Pharmacological therapies - Year-over-year growth 2022-2027 (%)
Exhibit 54: Data Table on Pharmacological therapies - Year-over-year growth 2022-2027 (%)
7.4 Non pharmacological therapies - Market size and forecast 2022-2027
Exhibit 55: Chart on Non pharmacological therapies - Market size and forecast 2022-2027 ($ million)
Exhibit 56: Data Table on Non pharmacological therapies - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Chart on Non pharmacological therapies - Year-over-year growth 2022-2027 (%)
Exhibit 58: Data Table on Non pharmacological therapies - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by Therapy
Exhibit 59: Market opportunity by Therapy ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 61: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 62: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 63: Chart on Geographic comparison
Exhibit 64: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 65: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 66: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 67: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 68: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 69: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 70: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 71: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 72: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 73: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 74: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 75: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 76: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 77: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 78: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 79: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 80: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 81: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 82: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 83: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 84: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Germany - Market size and forecast 2022-2027
Exhibit 85: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 86: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 87: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 88: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.9 China - Market size and forecast 2022-2027
Exhibit 89: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 90: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 91: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 92: Data Table on China - Year-over-year growth 2022-2027 (%)
9.10 UK - Market size and forecast 2022-2027
Exhibit 93: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 94: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 95: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 96: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.11 Japan - Market size and forecast 2022-2027
Exhibit 97: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 98: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 99: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 100: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 101: Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 102: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 103: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 104: Overview on factors of disruption
11.4 Industry risks
Exhibit 105: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 106: Vendors covered
12.2 Market positioning of vendors
Exhibit 107: Matrix on vendor position and classification
12.3 Apotex Inc.
Exhibit 108: Apotex Inc. - Overview
Exhibit 109: Apotex Inc. - Product/Service
Exhibit 110: Apotex Inc. - Key offerings
12.4 Assertio Therapeutics Inc.
Exhibit 111: Assertio Therapeutics Inc. - Overview
Exhibit 112: Assertio Therapeutics Inc. - Product/Service
Exhibit 113: Assertio Therapeutics Inc. - Key offerings
12.5 AstraZeneca Plc
Exhibit 114: AstraZeneca Plc - Overview
Exhibit 115: AstraZeneca Plc - Product/Service
Exhibit 116: AstraZeneca Plc - Key news
Exhibit 117: AstraZeneca Plc - Key offerings
12.6 Cadila Pharmaceuticals Ltd.
Exhibit 118: Cadila Pharmaceuticals Ltd. - Overview
Exhibit 119: Cadila Pharmaceuticals Ltd. - Product/Service
Exhibit 120: Cadila Pharmaceuticals Ltd. - Key offerings
12.7 Cipla Ltd.
Exhibit 121: Cipla Ltd. - Overview
Exhibit 122: Cipla Ltd. - Business segments
Exhibit 123: Cipla Ltd. - Key news
Exhibit 124: Cipla Ltd. - Key offerings
Exhibit 125: Cipla Ltd. - Segment focus
12.8 Daiichi Sankyo Co. Ltd.
Exhibit 126: Daiichi Sankyo Co. Ltd. - Overview
Exhibit 127: Daiichi Sankyo Co. Ltd. - Business segments
Exhibit 128: Daiichi Sankyo Co. Ltd. - Key news
Exhibit 129: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibit 130: Daiichi Sankyo Co. Ltd. - Segment focus
12.9 Dr Reddys Laboratories Ltd.
Exhibit 131: Dr Reddys Laboratories Ltd. - Overview
Exhibit 132: Dr Reddys Laboratories Ltd. - Business segments
Exhibit 133: Dr Reddys Laboratories Ltd. - Key offerings
Exhibit 134: Dr Reddys Laboratories Ltd. - Segment focus
12.10 Eli Lilly and Co.
Exhibit 135: Eli Lilly and Co. - Overview
Exhibit 136: Eli Lilly and Co. - Product/Service
Exhibit 137: Eli Lilly and Co. - Key offerings
12.11 Endo International Plc
Exhibit 138: Endo International Plc - Overview
Exhibit 139: Endo International Plc - Business segments
Exhibit 140: Endo International Plc - Key news
Exhibit 141: Endo International Plc - Key offerings
Exhibit 142: Endo International Plc - Segment focus
12.12 Hikma Pharmaceuticals Plc
Exhibit 143: Hikma Pharmaceuticals Plc - Overview
Exhibit 144: Hikma Pharmaceuticals Plc - Business segments
Exhibit 145: Hikma Pharmaceuticals Plc - Key offerings
Exhibit 146: Hikma Pharmaceuticals Plc - Segment focus
12.13 Johnson and Johnson
Exhibit 147: Johnson and Johnson - Overview
Exhibit 148: Johnson and Johnson - Business segments
Exhibit 149: Johnson and Johnson - Key news
Exhibit 150: Johnson and Johnson - Key offerings
Exhibit 151: Johnson and Johnson - Segment focus
12.14 Lupin Ltd.
Exhibit 152: Lupin Ltd. - Overview
Exhibit 153: Lupin Ltd. - Product/Service
Exhibit 154: Lupin Ltd. - Key news
Exhibit 155: Lupin Ltd. - Key offerings
12.15 Novartis AG
Exhibit 156: Novartis AG - Overview
Exhibit 157: Novartis AG - Business segments
Exhibit 158: Novartis AG - Key offerings
Exhibit 159: Novartis AG - Segment focus
12.16 Pfizer Inc.
Exhibit 160: Pfizer Inc. - Overview
Exhibit 161: Pfizer Inc. - Product/Service
Exhibit 162: Pfizer Inc. - Key news
Exhibit 163: Pfizer Inc. - Key offerings
12.17 Viatris Inc.
Exhibit 164: Viatris Inc. - Overview
Exhibit 165: Viatris Inc. - Business segments
Exhibit 166: Viatris Inc. - Key offerings
Exhibit 167: Viatris Inc. - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 168: Inclusions checklist
Exhibit 169: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 170: Currency conversion rates for US$
13.4 Research methodology
Exhibit 171: Research methodology
Exhibit 172: Validation techniques employed for market sizing
Exhibit 173: Information sources
13.5 List of abbreviations
Exhibit 174: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Type
Exhibits 6: Executive Summary - Chart on Market Segmentation by Therapy
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 18: Historic Market Size - Data Table on Global peripheral neuropathy treatment market 2017 - 2021 ($ million)
Exhibits 19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
Exhibits 20: Historic Market Size - Treatment Segment 2017 - 2021 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2022 and 2027
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits 26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits 27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits 28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits 29: Chart on Market condition - Five forces 2022 and 2027
Exhibits 30: Chart on Type - Market share 2022-2027 (%)
Exhibits 31: Data Table on Type - Market share 2022-2027 (%)
Exhibits 32: Chart on Comparison by Type
Exhibits 33: Data Table on Comparison by Type
Exhibits 34: Chart on Diabetic peripheral neuropathy - Market size and forecast 2022-2027 ($ million)
Exhibits 35: Data Table on Diabetic peripheral neuropathy - Market size and forecast 2022-2027 ($ million)
Exhibits 36: Chart on Diabetic peripheral neuropathy - Year-over-year growth 2022-2027 (%)
Exhibits 37: Data Table on Diabetic peripheral neuropathy - Year-over-year growth 2022-2027 (%)
Exhibits 38: Chart on Chemotherapy induced peripheral neuropathy - Market size and forecast 2022-2027 ($ million)
Exhibits 39: Data Table on Chemotherapy induced peripheral neuropathy - Market size and forecast 2022-2027 ($ million)
Exhibits 40: Chart on Chemotherapy induced peripheral neuropathy - Year-over-year growth 2022-2027 (%)
Exhibits 41: Data Table on Chemotherapy induced peripheral neuropathy - Year-over-year growth 2022-2027 (%)
Exhibits 42: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits 43: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits 44: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits 45: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits 46: Market opportunity by Type ($ million)
Exhibits 47: Chart on Therapy - Market share 2022-2027 (%)
Exhibits 48: Data Table on Therapy - Market share 2022-2027 (%)
Exhibits 49: Chart on Comparison by Therapy
Exhibits 50: Data Table on Comparison by Therapy
Exhibits 51: Chart on Pharmacological therapies - Market size and forecast 2022-2027 ($ million)
Exhibits 52: Data Table on Pharmacological therapies - Market size and forecast 2022-2027 ($ million)
Exhibits 53: Chart on Pharmacological therapies - Year-over-year growth 2022-2027 (%)
Exhibits 54: Data Table on Pharmacological therapies - Year-over-year growth 2022-2027 (%)
Exhibits 55: Chart on Non pharmacological therapies - Market size and forecast 2022-2027 ($ million)
Exhibits 56: Data Table on Non pharmacological therapies - Market size and forecast 2022-2027 ($ million)
Exhibits 57: Chart on Non pharmacological therapies - Year-over-year growth 2022-2027 (%)
Exhibits 58: Data Table on Non pharmacological therapies - Year-over-year growth 2022-2027 (%)
Exhibits 59: Market opportunity by Therapy ($ million)
Exhibits 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 61: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 62: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 63: Chart on Geographic comparison
Exhibits 64: Data Table on Geographic comparison
Exhibits 65: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 66: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 67: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits 68: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits 69: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 70: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 71: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 72: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 73: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 74: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 75: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 76: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 77: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 78: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 79: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 80: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 81: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits 82: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits 83: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits 84: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits 85: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 86: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 87: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 88: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 89: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits 90: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits 91: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits 92: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits 93: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 94: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 95: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits 96: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits 97: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits 98: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits 99: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits 100: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits 101: Market opportunity By Geographical Landscape ($ million)
Exhibits 102: Impact of drivers and challenges in 2022 and 2027
Exhibits 103: Overview on Criticality of inputs and Factors of differentiation
Exhibits 104: Overview on factors of disruption
Exhibits 105: Impact of key risks on business
Exhibits 106: Vendors covered
Exhibits 107: Matrix on vendor position and classification
Exhibits 108: Apotex Inc. - Overview
Exhibits 109: Apotex Inc. - Product/Service
Exhibits 110: Apotex Inc. - Key offerings
Exhibits 111: Assertio Therapeutics Inc. - Overview
Exhibits 112: Assertio Therapeutics Inc. - Product/Service
Exhibits 113: Assertio Therapeutics Inc. - Key offerings
Exhibits 114: AstraZeneca Plc - Overview
Exhibits 115: AstraZeneca Plc - Product/Service
Exhibits 116: AstraZeneca Plc - Key news
Exhibits 117: AstraZeneca Plc - Key offerings
Exhibits 118: Cadila Pharmaceuticals Ltd. - Overview
Exhibits 119: Cadila Pharmaceuticals Ltd. - Product/Service
Exhibits 120: Cadila Pharmaceuticals Ltd. - Key offerings
Exhibits 121: Cipla Ltd. - Overview
Exhibits 122: Cipla Ltd. - Business segments
Exhibits 123: Cipla Ltd. - Key news
Exhibits 124: Cipla Ltd. - Key offerings
Exhibits 125: Cipla Ltd. - Segment focus
Exhibits 126: Daiichi Sankyo Co. Ltd. - Overview
Exhibits 127: Daiichi Sankyo Co. Ltd. - Business segments
Exhibits 128: Daiichi Sankyo Co. Ltd. - Key news
Exhibits 129: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibits 130: Daiichi Sankyo Co. Ltd. - Segment focus
Exhibits 131: Dr Reddys Laboratories Ltd. - Overview
Exhibits 132: Dr Reddys Laboratories Ltd. - Business segments
Exhibits 133: Dr Reddys Laboratories Ltd. - Key offerings
Exhibits 134: Dr Reddys Laboratories Ltd. - Segment focus
Exhibits 135: Eli Lilly and Co. - Overview
Exhibits 136: Eli Lilly and Co. - Product/Service
Exhibits 137: Eli Lilly and Co. - Key offerings
Exhibits 138: Endo International Plc - Overview
Exhibits 139: Endo International Plc - Business segments
Exhibits 140: Endo International Plc - Key news
Exhibits 141: Endo International Plc - Key offerings
Exhibits 142: Endo International Plc - Segment focus
Exhibits 143: Hikma Pharmaceuticals Plc - Overview
Exhibits 144: Hikma Pharmaceuticals Plc - Business segments
Exhibits 145: Hikma Pharmaceuticals Plc - Key offerings
Exhibits 146: Hikma Pharmaceuticals Plc - Segment focus
Exhibits 147: Johnson and Johnson - Overview
Exhibits 148: Johnson and Johnson - Business segments
Exhibits 149: Johnson and Johnson - Key news
Exhibits 150: Johnson and Johnson - Key offerings
Exhibits 151: Johnson and Johnson - Segment focus
Exhibits 152: Lupin Ltd. - Overview
Exhibits 153: Lupin Ltd. - Product/Service
Exhibits 154: Lupin Ltd. - Key news
Exhibits 155: Lupin Ltd. - Key offerings
Exhibits 156: Novartis AG - Overview
Exhibits 157: Novartis AG - Business segments
Exhibits 158: Novartis AG - Key offerings
Exhibits 159: Novartis AG - Segment focus
Exhibits 160: Pfizer Inc. - Overview
Exhibits 161: Pfizer Inc. - Product/Service
Exhibits 162: Pfizer Inc. - Key news
Exhibits 163: Pfizer Inc. - Key offerings
Exhibits 164: Viatris Inc. - Overview
Exhibits 165: Viatris Inc. - Business segments
Exhibits 166: Viatris Inc. - Key offerings
Exhibits 167: Viatris Inc. - Segment focus
Exhibits 168: Inclusions checklist
Exhibits 169: Exclusions checklist
Exhibits 170: Currency conversion rates for US$
Exhibits 171: Research methodology
Exhibits 172: Validation techniques employed for market sizing
Exhibits 173: Information sources
Exhibits 174: List of abbreviations
Executive Summary
The publisher recognizes the following companies as the key players in the global peripheral neuropathy treatment market: Apotex Inc., Assertio Therapeutics Inc., AstraZeneca Plc, Cadila Pharmaceuticals Ltd., Cipla Ltd., Daiichi Sankyo Co. Ltd., Dr Reddys Laboratories Ltd., Eli Lilly and Co., Endo International Plc, Grunenthal GmbH, Hikma Pharmaceuticals Plc, Johnson and Johnson, Lupin Ltd., Novartis AG, Pfizer Inc., Shionogi and Co. Ltd., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., UCB SA, and Viatris Inc.Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is strong drug pipeline.`
According to the report, one of the major drivers for this market is the increasing prevalence of peripheral neuropathy.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Apotex Inc.
- Assertio Therapeutics Inc.
- AstraZeneca Plc
- Cadila Pharmaceuticals Ltd.
- Cipla Ltd.
- Daiichi Sankyo Co. Ltd.
- Dr Reddys Laboratories Ltd.
- Eli Lilly and Co.
- Endo International Plc
- Grunenthal GmbH
- Hikma Pharmaceuticals Plc
- Johnson and Johnson
- Lupin Ltd.
- Novartis AG
- Pfizer Inc.
- Shionogi and Co. Ltd.
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- UCB SA
- Viatris Inc.
